Michael J Kerin

researcher (ORCID 0000-0003-4164-5561)

Michael J Kerin is …
instance of (P31):
humanQ5

External links are
P496ORCID iD0000-0003-4164-5561
P1153Scopus author ID26631163000

P108employerUniversity of GalwayQ644478
P735given nameMichaelQ4927524
MichaelQ4927524
P106occupationresearcherQ1650915
P21sex or gendermaleQ6581097

Reverse relations

author (P50)
Q50714110"Excuse me:" teaching interns to speak up.
Q3601638611q13 is a susceptibility locus for hormone receptor positive breast cancer
Q3587156719p13.1 is a triple-negative-specific breast cancer susceptibility locus
Q371698739q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium
Q92945512A Review of the Impact of Neoadjuvant Chemotherapy on Breast Surgery Practice and Outcomes
Q37619303A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium
Q38264727A review of sentinel lymph node biopsy for thin melanoma
Q57305942A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer
Q43131010Adipose-Derived Stem Cells in Novel Approaches to Breast Reconstruction: Their Suitability for Tissue Engineering and Oncological Safety
Q40585434Analysis of subsequent publication and impact of abstracts presented at the Sir Peter Freyer Surgical Symposium: Focus on the Plenary Session
Q45979098Association analysis identifies 65 new breast cancer risk loci.
Q35022847Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies
Q35532898Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium
Q57056093Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis
Q35061513Awareness and uptake of family screening in patients diagnosed with colorectal cancer at a young age.
Q44288178CYP3A variation, premenopausal estrone levels, and breast cancer risk
Q38644736Clinical and economic benefit of general practitioner integration to a symptomatic breast service
Q33766513Clinical use of the Oncotype DX genomic test to guide treatment decisions for patients with invasive breast cancer
Q35794653Common germline polymorphisms associated with breast cancer-specific survival
Q34379032Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium
Q31082788Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)
Q34181322Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer
Q57278898Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)
Q35768989Cross Platform Standardisation of an Experimental Pipeline for Use in the Identification of Dysregulated Human Circulating MiRNAs
Q99419831Effect of Breast Cancer and Adjuvant Therapy on Adipose-Derived Stromal Cells: Implications for the Role of ADSCs in Regenerative Strategies for Breast Reconstruction
Q44569975Endoscopic management of common duct stones with laparoscopic cholecystectomy
Q35064451Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation
Q38832499Exosome-encapsulated microRNAs as circulating biomarkers for breast cancer
Q40661127FNAC and frozen section correlations with definitive histology in thyroid diseases
Q35524465Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.
Q61230414Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes
Q92480972Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
Q34903062Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.
Q37367871Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1.
Q36742577Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers
Q35925620Genetic predisposition to ductal carcinoma in situ of the breast
Q35151684Genetic predisposition to in situ and invasive lobular carcinoma of the breast
Q35179897Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study
Q34378972Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade
Q36842233Genome-wide association analysis identifies three new breast cancer susceptibility loci
Q35996692Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer
Q24622610Genome-wide association studies identify four ER negative-specific breast cancer risk loci
Q64040390Genome-wide association study of germline variants and breast cancer-specific mortality
Q36276540Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization
Q58599232Hydrogels in adipose tissue engineering-Potential application in post-mastectomy breast regeneration
Q35102646Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk
Q36086247Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus
Q36014067Identification of novel genetic markers of breast cancer survival
Q46103372Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer
Q35104068Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer
Q42377099Investigating the association of rs2910164 with cancer predisposition in an Irish cohort
Q29416989Large-scale genotyping identifies 41 new loci associated with breast cancer risk
Q34497352MicroRNA related polymorphisms and breast cancer risk
Q35057393Mismatch repair protein expression in colorectal cancer
Q36897003Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
Q30374367No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Q64952029Outcome for triple negative breast cancer in a retrospective cohort with an emphasis on response to platinum-based neoadjuvant therapy.
Q28584533PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS
Q47143943PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1.
Q24672741Pathology and clinical relevance of radial scars: a review
Q62583133Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
Q36583004Prediction of breast cancer risk based on profiling with common genetic variants
Q38918206Prospective comparison of outcome after treatment for triple-negative and non-triple-negative breast cancer
Q55508030Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.
Q71816302Results of a prospective randomized trial using DTIC and interferon as adjuvant therapy for stage I malignant melanoma
Q92359744Serial CRP levels following oesophagectomy: a marker for anastomotic dehiscence
Q92695694Super-resolution radar imaging for breast cancer detection with microwaves: the integrated information selection criteria
Q35068495The acquisition and retention of urinary catheterisation skills using surgical simulator devices: teaching method or student traits
Q49720647The clinical utility of pre-operative neutrophil-to-lymphocyte ratio as a predictor of outcomes in patients undergoing elective laparoscopic cholecystectomy.
Q48359353The future of UK/Irish surgery: A European solution
Q34376320The impact of Oncotype DX testing on breast cancer management and chemotherapy prescribing patterns in a tertiary referral centre
Q46928066The oncologic safety and practicality of breast conservation surgery in large breast tumors 5 centimeters or more
Q35535359The use of circulating microRNAs as diagnostic biomarkers in colorectal cancer
Q79259558The value of axillary lymphadenectomy
Q47922430Total systemic ropivacaine concentrations following aerosolized intraperitoneal delivery using the AeroSurge
Q47694980You've Got to Hand It to Them: Assessing Final Year Medical Students Knowledge of Hand Anatomy and Pathology

Search more.